Automate and Close CGT Processes
Products & Services
Information
As cell and gene therapies (CGTs) progress from discovery to commercial delivery, the need for automation, safety, and consistency becomes critical. Open systems increase risk, variability, and labor costs, especially in cleanroom environments. That’s why BioLife Solutions offers a suite of closed-system cell processing tools to help therapy developers and CDMOs streamline workflows, reduce contamination risk, and improve scalability.
